Gen-Probe CFO Maps Out Short-term Opportunities at Jefferies Conference | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Amid speculation that Gen-Probe's reported search for a buyer may have gotten a tepid response, CFO Herm Rosenman focused his presentation Tuesday at the Jefferies Global Healthcare Conference on growth opportunities for the firm's new Panther platform and testing markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.